Amarin Corp Plc (AMRN)

[NickHous]

Excellent point regarding trials being disrupted by the corona virus. This bodes well for AMRN and Vascepa Red-It being "in the books" as a major success. FDA label expansion is behind us. We were right on the edge of a major launch going into this CV, so really in the big scheme of things AMRN has not wasted any initial ramp momentum and then would have to try and regain momentum again once this ends. Even the sales reps hadn't really been turned loose with a full arsenal yet. When they do re-enter "the wild" they should be very well trained on any and every aspect of Vascepa push-back coming from doctors. Timing of DTC ads will coincide with "other side" of CV. It will all be BRAND NEW to the public when they see these expanded label touting ads. The one thing I want to see in these ads is to say Lovaza/Generic Lovaza is NOT an equal or generic substitute of Vascepa. Eliminate and take those GL/L prescriptions right off the bat and go from there. We are the standard of care! All JMO.
Of course the big de-risker is coming out of Nevada. And I'm not talking about KG announcing excellent room rates for LV II!